Evotec Announces CFO Transition: Paul Hitchin Steps Down, Claire Hinshelwood Appointed

summarizeSummary

Evotec SE announced a change in its Chief Financial Officer role, with Paul Hitchin stepping down for personal reasons and Claire Hinshelwood, an experienced financial leader, appointed as his successor.

check_boxKey Events

• Chief Financial Officer Departure

  Paul Hitchin will step down as Chief Financial Officer of Evotec SE on April 30, 2026, for personal reasons unrelated to the company.

• New CFO Appointment

  Claire Hinshelwood has been appointed as the new Chief Financial Officer, effective May 1, 2026. She brings over 30 years of financial leadership experience, including roles at BMI Group, Novartis, and Syngenta.

• Strategic Focus

  The company expects the new CFO's expertise to advance its progress toward increased profitability and sustainable growth during its ongoing business transformation.

auto_awesomeAnalysis

The transition in Evotec's Chief Financial Officer role is a significant leadership change. While Paul Hitchin's departure for personal reasons is noted, the appointment of Claire Hinshelwood, with over 30 years of financial leadership experience including roles at BMI Group and Novartis, is a strong positive. Her expertise is expected to support the company's strategic goals of increased profitability and sustainable growth, providing continuity and new perspectives during a period of business transformation.